These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16987245)

  • 1. Glial fibrillary acidic protein is a major target of glycoxidative and lipoxidative damage in Pick's disease.
    Muntané G; Dalfó E; Martínez A; Rey MJ; Avila J; Pérez M; Portero M; Pamplona R; Ayala V; Ferrer I
    J Neurochem; 2006 Oct; 99(1):177-85. PubMed ID: 16987245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type-dependent oxidative damage in frontotemporal lobar degeneration: cortical astrocytes are targets of oxidative damage.
    Martínez A; Carmona M; Portero-Otin M; Naudí A; Pamplona R; Ferrer I
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1122-36. PubMed ID: 19018247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter: a variant of corticobasal degeneration?
    Tan CF; Piao YS; Kakita A; Yamada M; Takano H; Tanaka M; Mano A; Makino K; Nishizawa M; Wakabayashi K; Takahashi H
    Acta Neuropathol; 2005 Mar; 109(3):329-38. PubMed ID: 15841415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
    Zhukareva V; Mann D; Pickering-Brown S; Uryu K; Shuck T; Shah K; Grossman M; Miller BL; Hulette CM; Feinstein SC; Trojanowski JQ; Lee VM
    Ann Neurol; 2002 Jun; 51(6):730-9. PubMed ID: 12112079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobar atrophy without Pick bodies.
    Hulette CM; Crain BJ
    Clin Neuropathol; 1992; 11(3):151-6. PubMed ID: 1611728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders.
    Schofield E; Kersaitis C; Shepherd CE; Kril JJ; Halliday GM
    Brain; 2003 Apr; 126(Pt 4):827-40. PubMed ID: 12615642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidation, glycoxidation, lipoxidation, nitration, and responses to oxidative stress in the cerebral cortex in Creutzfeldt-Jakob disease.
    Freixes M; Rodríguez A; Dalfó E; Ferrer I
    Neurobiol Aging; 2006 Dec; 27(12):1807-15. PubMed ID: 16310893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased proteins in post-mortem brain in a case of Pick's disease and in Huntington's disease.
    Borthwick NM; Gordon A; Yates CM
    J Neurol Sci; 1985 Dec; 71(2-3):377-86. PubMed ID: 2935597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease.
    Kobayashi K; Hayashi M; Nakano H; Fukutani Y; Sasaki K; Shimazaki M; Koshino Y
    Neuropathol Appl Neurobiol; 2002 Jun; 28(3):238-51. PubMed ID: 12060348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KP1 expression of ghost Pick bodies, amyloid P-positive astrocytes and selective nigral degeneration in early onset Picks disease.
    Kobayashi K; Hayashi M; Fukutani Y; Miyazu K; Shiozawa M; Muramori F; Aoki T; Koshino Y
    Clin Neuropathol; 1999; 18(5):240-9. PubMed ID: 10505433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pick's disease with neuronal four-repeat tau accumulation in the basal ganglia, brain stem nuclei and cerebellum.
    Ikeda C; Yokota O; Miki T; Takenoshita S; Ishizu H; Mori Y; Yamazaki K; Ozaki Y; Ueno SI; Ishihara T; Hasegawa M; Terada S; Yamada N
    Neuropathology; 2017 Dec; 37(6):544-559. PubMed ID: 28691164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography and histopathology in Pick's disease.
    Kamo H; McGeer PL; Harrop R; McGeer EG; Calne DB; Martin WR; Pate BD
    Neurology; 1987 Mar; 37(3):439-45. PubMed ID: 3493451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hereditary Pick's disease with the G272V tau mutation shows predominant three-repeat tau pathology.
    Bronner IF; ter Meulen BC; Azmani A; Severijnen LA; Willemsen R; Kamphorst W; Ravid R; Heutink P; van Swieten JC
    Brain; 2005 Nov; 128(Pt 11):2645-53. PubMed ID: 16014652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
    Ferrer I; Barrachina M; Puig B
    Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal and glial tau pathology in early frontotemporal lobar degeneration-tau, Pick's disease subtype.
    Mimuro M; Yoshida M; Miyao S; Harada T; Ishiguro K; Hashizume Y
    J Neurol Sci; 2010 Mar; 290(1-2):177-82. PubMed ID: 20022024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of oxidative stress in the neocortex in incidental Lewy body disease.
    Dalfó E; Portero-Otín M; Ayala V; Martínez A; Pamplona R; Ferrer I
    J Neuropathol Exp Neurol; 2005 Sep; 64(9):816-30. PubMed ID: 16141792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological study of two subtypes of Pick's disease in Japan.
    Odawara T; Iseki E; Kanai A; Arai T; Katsuragi T; Hino H; Furukawa Y; Kato M; Yamamoto T; Kosaka K
    Dement Geriatr Cogn Disord; 2003; 15(1):19-25. PubMed ID: 12457075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Astrocytic straight tubules in the brain of a patient with Pick's disease.
    Yamazaki M; Nakano I; Imazu O; Kaieda R; Terashi A
    Acta Neuropathol; 1994; 88(6):587-91. PubMed ID: 7879608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies.
    Odawara T; Shiozaki K; Iseki E; Hino H; Kosaka K
    J Neurol Neurosurg Psychiatry; 2003 Jul; 74(7):965-7. PubMed ID: 12810794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
    Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
    Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.